McKesson
Market cap
$124.380 B
$1,077.29 +0.73%
Close of 6 Nov 2026
As of 6 Nov 2026, McKesson (MCK) has a market capitalization of $124.4B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$403.4B
#5 by revenue
Earnings
$4.76B
#105 by earnings
Shares outstanding
115,456,664
Latest filing cover page
P/E ratio
26.1
Cap ÷ net income
Other Pharmaceuticals, ranked by market cap
All 10 →- #1McKessonMCK$124.4B
- #2CencoraCOR$64.9B
- #3Cardinal HealthCAH$62.4B
- #4HerbalifeHLF$1.57B
- #5Nu Skin EnterprisesNUS$221.7M
What if McKesson were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for McKesson are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.